Silence Therapeutics plc (SLNCF) Free cash flow 2022–2025
Silence Therapeutics plc (SLNCF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$62.3MFY2025 · since FY2022: -$57.2M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.3M | +8.1% |
| FY2024 | -$67.9M | -37.0% |
| FY2023 | -$49.5M | +13.5% |
| FY2022 | -$57.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice